Background Recently, neutrophil to lymphocyte ratio (N/L) as showing inflammatory and oxidative stress has been widely studied in various cardiovascular diseases. There is no data regarding the relationship between this…
Objectives Previous studies showed the association between the major adverse cardiovascular outcomes and both higher neutrophil and lower lymphocyte counts. Sufficient coronary collateral development has important preventive role against unstable…
Drug eluting stents have become an important component in percutaneous treatment of patients with symptomatic coronary artery disease. Drug eluting stents have been used more frequently in patient presented with…
Drug eluting stents have become an important component in percutaneous treatment of patients with symptomatic coronary artery disease. There are limited data to evaluate effectiveness and safety of drug eluting…
Introduction Platelet activation appears to play an important role in thromboembolic complications of infective endocarditis (IE). Mean platelet volume (MPV) is a potentially usefull marker of platelet activity and a…
Objective Several studies have shown the association between STEMI and circadian rhythm. Nonetheless, intrinsic circadian release or sequestering of platelets is controlled by various humoral factors, including hormones, endothelial-derived factors,…
The neutrophil–lymphocyte ratio (NLR) is an inflammatory marker of adverse cardiac events in STEMI. Whether admission NLRs before a successful primary percutaneous coronary intervention (PCI) directly reflect a larger myocardial…
Objectives Platelet/lymphocyte ratio (PLR) has been shown as an inflammatory biomarkers for coronary heart disease, but data regarding the association of PLR with coronary blood flow in ST-segment elevation myocardial…
Background Major limitation for the use of stent in the treatment of coronary artery disease are development of stent restenosis and stent thrombosis. The impact of post dilatation on angiographic…
Aim Argues continue about primary angioplasty procedures at hospitals without on- site cardiac surgery. We aim to present and compare with the litreature the results of our center without on-…
